1466 — Baijin Life Science Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Baijin Life Science Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	23.6	41.3	37.9	47.8	43.1
Net Total Accounts Receivable
Net Total Receivables	26.6	7.44	30.2	97	59.7
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	79.6	98.9	121	227	192
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.55	0.979	8.78	16.8	30.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	82.1	99.9	197	290	264
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45.5	21.1	41	49.7	64.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	46.2	21.6	100	151	79.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	35.9	78.3	96.3	139	185
Total Liabilities & Shareholders' Equity	82.1	99.9	197	290	264
Total Common Shares Outstanding